IP Library Assignment 073465/0174
Patent Assignment
Reel/Frame 073465/0174

Assignment of Assignor's Interest

Recorded: 2025-11-05 Pages: 24
Assignor
SAVIENT PHARMACEUTICALS, INC.
Executed: 2014-01-09
Assignee
CREALTA PHARMACEUTICALS LLC
150 S. SAUNDERS RD., LAKE FOREST, ILLINOIS, 60045
Covered Property (1)
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Application: 19/345,445 →
Publication: US 2026/0023073
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 5, 2025
From: ROSARIO-JANSEN, THERESA; WRIGHT, DAVID ERICK
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 072794/0436 →
Change of Name Nov 5, 2025
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 073465/0241 →
Assignment of Assignor's Interest Nov 5, 2025
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 073465/0721 →